1. Cost-Minimization Analysis of Direct Cost of Sevelamer Carbonate and Lanthanum Carbonate in the Treatment of Patients with Chronic Kidney Disease Not on Dialysis in Bulgaria 
Martin Petrov, MSc, Maria Dimitrova, PhD, Guenka Petrova, DSc 
Value in Health Regional Issues 
Volume 7, Pages (September 2015)
DOI: /j.vhri
Copyright © 2015 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions

2. Fig. 1
Tornado diagram presenting the changes in cost savings when individual parameter values are varied (4000 mg SC vs mg LC dose regimens for patient allocation SC 100% vs. SC 50%:LC 50%). LC, lanthanum carbonate; SC, sevelamer carbonate.
Value in Health Regional Issues 2015 7, DOI: ( /j.vhri )
Copyright © 2015 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions

3. Fig. 2
Tornado diagram presenting the changes in cost savings when individual parameter values are varied (4000 mg SC vs mg LC dose regimens for patient allocation SC 100% vs. LC 100%). LC, lanthanum carbonate; SC, sevelamer carbonate.
Value in Health Regional Issues 2015 7, DOI: ( /j.vhri )
Copyright © 2015 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions